Skip to main content
. 2010 Nov 18;300(2):G191–G201. doi: 10.1152/ajpgi.00496.2010

Fig. 1.

Fig. 1.

Factors and mechanisms associated with bone mass loss and increased risk of fractures in patients with inflammatory bowel diseases. IBD, inflammatory bowel disease; RANKL, receptor activator of NF-κB ligand; OPG, osteoprotegerin.